Company Filing History:
Years Active: 2021-2023
Title: Innovations by Derek G Van Der Poll
Introduction
Derek G Van Der Poll is an accomplished inventor based in Medford, MA (US). He has made significant contributions to the field of hydrogel formulations, focusing on non-injectable delivery systems for therapeutic agents. With a total of two patents to his name, his work is paving the way for advancements in medical treatments.
Latest Patents
Derek's latest patents include innovative formulations that enhance the delivery of therapeutic agents. One of his notable inventions is a non-injectable hydrogel formulation designed for smart release. This formulation utilizes self-assembling hydrogels made from Generally Regarded as Safe (GRAS) compounds, such as ascorbyl palmitate. It can be administered in various forms, including capsules, tablets, oral suspensions, enemas, and suppositories. The formulation is particularly effective in delivering anti-inflammatories and anti-infectives, especially when lower blood levels relative to tissue levels are desired. Another significant patent involves the formulation of nanostructured gels that allow for high agent loading, particularly for amine-containing compounds like local anesthetics. This innovation addresses the challenges of encapsulating such agents and enhances their adhesion to charged surfaces, mimicking inflamed tissue.
Career Highlights
Derek G Van Der Poll is currently associated with Alivio Therapeutics, Inc., where he continues to develop groundbreaking hydrogel technologies. His work is instrumental in advancing the field of drug delivery systems, making treatments more effective and patient-friendly.
Collaborations
Derek collaborates with talented professionals in his field, including Dominick J Blasioli and Gregory T Zugates. These partnerships enhance the innovative potential of his projects and contribute to the success of their shared goals.
Conclusion
Derek G Van Der Poll is a notable inventor whose work in hydrogel formulations is transforming the landscape of medical treatments. His patents reflect a commitment to improving drug delivery systems, ultimately benefiting patients and healthcare providers alike.